Monteris Medical

Monteris Medical is a private medical device company and the established leader in MRI-guided laser ablation for the brain. Its core technology, the NeuroBlate System, is the only robotic LITT platform designed specifically for neurosurgical applications, enabling precise, real-time thermal ablation of targeted brain tissue. The company has built a significant body of prospective clinical evidence, including the landmark LAANTERN registry and a first-of-its-kind randomized controlled trial for recurrent brain metastases, to drive clinical adoption. Monteris operates in the high-growth neurosurgery and neuro-oncology markets, focusing on providing a less invasive alternative to open brain surgery.

The NeuroBlate System is a robotic, MRI-guided Laser Interstitial Thermal Therapy (LITT) platform designed specifically for minimally invasive ablation procedures in the brain. It integrates a robotic aiming device (AtamA), an MRI-compatible cranial bolt (MiniBolt), and a laser probe with real-time MRI thermometry for precise visualization and control of thermal ablation.

Monteris is the recognized leader in dedicated MRI-guided LITT for the brain. Competition includes other energy-based ablation technologies like MRI-guided focused ultrasound (e.g., Insightec) and companies offering generic laser systems that can be adapted for neurosurgery. Monteris's key differentiator is its brain-specific design and unparalleled portfolio of prospective clinical evidence.